310 reports of this reaction
2.0% of all AMPICILLIN reports
#10 most reported adverse reaction
RENAL FAILURE is the #10 most commonly reported adverse reaction for AMPICILLIN, manufactured by Armas Pharmaceuticals Inc.. There are 310 FDA adverse event reports linking AMPICILLIN to RENAL FAILURE. This represents approximately 2.0% of all 15,856 adverse event reports for this drug.
Patients taking AMPICILLIN who experience renal failure should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
RENAL FAILURE is a less commonly reported adverse event for AMPICILLIN, but still significant enough to appear in the safety profile.
In addition to renal failure, the following adverse reactions have been reported for AMPICILLIN:
The following drugs have also been linked to renal failure in FDA adverse event reports:
RENAL FAILURE has been reported as an adverse event in 310 FDA reports for AMPICILLIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
RENAL FAILURE accounts for approximately 2.0% of all adverse event reports for AMPICILLIN, making it a notable side effect.
If you experience renal failure while taking AMPICILLIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.